Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Evaluation of Tuberculosis Underreporting to National Tuberculosis Program (NTBP) based on data from laboratories in Tehran and NTBP.

Bakhtiari A, Nasehi M, Rashidian A, Arab M, Sharafi S, Mokhtari S.

Med J Islam Repub Iran. 2019 Jul 17;33:70. doi: 10.34171/mjiri.33.70. eCollection 2019.

2.

Factors associated with mortality from tuberculosis in Iran: an application of a generalized estimating equation-based zero-inflated negative binomial model to national registry data.

Sarvi F, Moghimbeigi A, Mahjub H, Nasehi M, Khodadost M.

Epidemiol Health. 2019;41:e2019032. doi: 10.4178/epih.e2019032. Epub 2019 Jul 9.

3.

The human microbiota in pulmonary tuberculosis: Not so innocent bystanders.

Tarashi S, Ahmadi Badi S, Moshiri A, Nasehi M, Fateh A, Vaziri F, Siadat SD.

Tuberculosis (Edinb). 2018 Dec;113:215-221. doi: 10.1016/j.tube.2018.10.010. Epub 2018 Oct 29. Review.

PMID:
30514505
4.

The relationship between social capital components and control of type 2 diabetes: A path analysis model.

Moradi Y, Nasehi M, Asadi-Lari M, Khamseh ME, Baradaran HR.

Med J Islam Repub Iran. 2017 Mar 14;31:21. doi: 10.18869/mjiri.31.21. eCollection 2017.

5.

Epidemiology of Leprosy in Iran from 2005 to 2015.

Mansori K, Ayubi E, Nasehi M, Mansouri Hanis S, Amiri B, Khazaei S.

Tanaffos. 2017;16(2):144-148.

6.

Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis.

Jimma W, Ghazisaeedi M, Shahmoradi L, Abdurahman AA, Kalhori SRN, Nasehi M, Yazdi S, Safdari R.

Rev Soc Bras Med Trop. 2017 May-Jun;50(3):287-295. doi: 10.1590/0037-8682-0002-2017. Review.

7.

Prevalence of latent tuberculosis infection among tuberculosis laboratory workers in Iran.

Nasehi M, Hashemi-Shahraki A, Doosti-Irani A, Sharafi S, Mostafavi E.

Epidemiol Health. 2016 Dec 30;39:e2017002. doi: 10.4178/epih.e2017002. eCollection 2017.

8.

The examination of relationship between socioeconomic factors and number of tuberculosis using quantile regression model for count data in Iran 2010-2011.

Sarvi F, Momenian S, Khodadost M, Pahlavanzadeh B, Nasehi M, Sekhavati E.

Med J Islam Repub Iran. 2016 Jul 17;30:399. eCollection 2016.

9.

Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran.

Mostafavi E, Nasehi M, Hashemi Shahraki A, Esmaeili S, Ghaderi E, Sharafi S, Doosti-Irani A.

Epidemiol Health. 2016 Jul 24;38:e2016032. doi: 10.4178/epih.e2016032. eCollection 2016.

10.

Predicting the Incidence of Smear Positive Tuberculosis Cases in Iran Using Time Series Analysis.

Moosazadeh M, Khanjani N, Nasehi M, Bahrampour A.

Iran J Public Health. 2015 Nov;44(11):1526-34.

11.

The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study.

Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N.

Lung India. 2015 Nov-Dec;32(6):557-60. doi: 10.4103/0970-2113.168113.

12.

Lack of optimum practice among health care workers regarding tuberculosis in Iran: A knowledge, attitude, and practice study.

Doosti Irani A, Hashemi Shahraki A, Ghaderi E, Nasehi M, Mostafavi E.

Am J Infect Control. 2015 May 1;43(5):e7-12. doi: 10.1016/j.ajic.2015.01.020. Epub 2015 Feb 25.

PMID:
25726128
13.

Estimating the annual risk of tuberculosis infection and disease in southeast of iran using the bayesian mixture method.

Haghdoost AA, Afshari M, Baneshi MR, Gouya MM, Nasehi M, Movahednia M.

Iran Red Crescent Med J. 2014 Sep 5;16(9):e15308. doi: 10.5812/ircmj.15308. eCollection 2014 Sep.

14.

Cost of illness of tuberculosis in tehran in the year 2011.

Hasoumi M, Nasehi M, Khakian M, Mohseni M, Ziaiifar H, Keykale MS.

Mater Sociomed. 2014 Oct;26(5):339-42. doi: 10.5455/msm.2014.26.339-342. Epub 2014 Oct 29.

15.

Survival and Predictors of Death after Successful Treatment among Smear Positive Tuberculosis: A Cohort Study.

Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N.

Int J Prev Med. 2014 Aug;5(8):1005-12.

16.

Forecasting tuberculosis incidence in iran using box-jenkins models.

Moosazadeh M, Nasehi M, Bahrampour A, Khanjani N, Sharafi S, Ahmadi S.

Iran Red Crescent Med J. 2014 May;16(5):e11779. doi: 10.5812/ircmj.11779. Epub 2014 May 5.

17.

Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis.

Amiri FB, Gouya MM, Saifi M, Rohani M, Tabarsi P, Sedaghat A, Fahimfar N, Memarnejadian A, Aghasadeghi MR, Haghdoost AA, Jahanbakhsh F, Nasehi M, Mostafavi E.

PLoS One. 2014 Jun 4;9(6):e98742. doi: 10.1371/journal.pone.0098742. eCollection 2014.

18.

Does tuberculosis have a seasonal pattern among migrant population entering Iran?

Moosazadeh M, Khanjani N, Bahrampour A, Nasehi M.

Int J Health Policy Manag. 2014 May 3;2(4):181-5. doi: 10.15171/ijhpm.2014.43. eCollection 2014 May.

19.

Inequality of leprosy disability in iran, clinical or socio-economic inequality: an extended concentration index decomposition approach.

Entezarmahdi R, Majdzadeh R, Foroushani AR, Nasehi M, Lameei A, Naieni KH.

Int J Prev Med. 2014 Apr;5(4):414-23.

20.

What Is the Share of the Country's Researches in Iran's National Tuberculosis Guideline?

Majdzadeh R, Rahmani K, Nasehi M.

Iran J Public Health. 2013 Dec;42(12):1405-13.

21.

Diagnosis delay in smear positive tuberculosis patients.

Nasehi M, Hassanzadeh J, Rezaianzadeh A, Zeigami B, Tabatabaee H, Ghaderi E.

J Res Med Sci. 2012 Nov;17(11):1001-4.

22.

Pattern of reported tuberculosis cases in iran 2009-2010.

Hassan Zadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E.

Iran J Public Health. 2013;42(1):72-8. Epub 2013 Jan 1.

23.

Management of MDR-TB: Review of Iran's Experience.

Masjedi MR, Tabarsi P, Marjani M, Shiva PB, Nasehi M, Gooya MM, Farnia P, Velayati AA.

Tanaffos. 2013;12(1):6-15. Review. No abstract available.

Supplemental Content

Loading ...
Support Center